AU762100B2 - Protective antigen of group A Streptococci (SPA) - Google Patents

Protective antigen of group A Streptococci (SPA) Download PDF

Info

Publication number
AU762100B2
AU762100B2 AU23846/00A AU2384600A AU762100B2 AU 762100 B2 AU762100 B2 AU 762100B2 AU 23846/00 A AU23846/00 A AU 23846/00A AU 2384600 A AU2384600 A AU 2384600A AU 762100 B2 AU762100 B2 AU 762100B2
Authority
AU
Australia
Prior art keywords
spa
polypeptide
isolated
nucleic acid
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU23846/00A
Other languages
English (en)
Other versions
AU2384600A (en
Inventor
James Dale
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Tennessee Research Foundation
Original Assignee
University of Tennessee Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Tennessee Research Foundation filed Critical University of Tennessee Research Foundation
Publication of AU2384600A publication Critical patent/AU2384600A/en
Application granted granted Critical
Publication of AU762100B2 publication Critical patent/AU762100B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU23846/00A 1998-12-22 1999-12-22 Protective antigen of group A Streptococci (SPA) Ceased AU762100B2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US11379498P 1998-12-22 1998-12-22
US60/113794 1998-12-22
US11473098P 1998-12-31 1998-12-31
US60/114730 1998-12-31
PCT/US1999/030807 WO2000037648A1 (fr) 1998-12-22 1999-12-22 Antigene protecteur de streptococci de groupe a (spa)

Publications (2)

Publication Number Publication Date
AU2384600A AU2384600A (en) 2000-07-12
AU762100B2 true AU762100B2 (en) 2003-06-19

Family

ID=26811487

Family Applications (1)

Application Number Title Priority Date Filing Date
AU23846/00A Ceased AU762100B2 (en) 1998-12-22 1999-12-22 Protective antigen of group A Streptococci (SPA)

Country Status (5)

Country Link
EP (1) EP1141311A1 (fr)
JP (1) JP2002533084A (fr)
AU (1) AU762100B2 (fr)
CA (1) CA2353802C (fr)
WO (1) WO2000037648A1 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6716433B1 (en) 1997-09-12 2004-04-06 University Of Tennessee Research Foundation Group a streptococcal vaccines
CA2463008A1 (fr) * 2001-10-26 2003-07-24 Id Biomedical Corporation Of Washington Systeme d'expression de proteine efficace
US7255867B2 (en) 2002-11-15 2007-08-14 Id Biomedical Corporation Of Quebec Vaccine
EP3023140B1 (fr) 2003-04-10 2019-10-09 President and Fellows of Harvard College Formation et régulation d'espèces fluidiques
CN104069784B (zh) 2003-08-27 2017-01-11 哈佛大学 流体物种的电子控制
EP2319862A1 (fr) * 2006-07-07 2011-05-11 Intercell AG Petits antigènes pyogènes streptococcus et leur utilisation
CN107050442B (zh) 2008-11-05 2022-09-13 惠氏有限责任公司 用于预防β-溶血链球菌(BHS)疾病的多组分免疫原性组合物
CA2838981C (fr) 2011-06-17 2020-09-08 University Of Tennessee Research Foundation Vaccin multivalent contre un streptocoque du groupe a
WO2014124446A1 (fr) 2013-02-11 2014-08-14 University Of Tennessee Research Foundation Protéines apparentées à m de streptocoque de groupe a et leurs procédés d'utilisation
CN118388609B (zh) * 2024-04-24 2025-03-25 青岛立见生物科技有限公司 一种低浓度酶标记链球菌蛋白g的稳定保护剂

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0618813B1 (fr) * 1992-09-16 2002-01-09 The University Of Tennessee Research Corporation Antigene de la proteine m hybride et porteur destine au vaccin anti-streptococcique du groupe a
IL107025A0 (en) * 1992-09-16 1993-12-28 Univ Tennessee Res Corp Recombinant multivalent m protein vaccine
IES76925B2 (en) * 1996-07-03 1997-11-19 Provost Subunit Vaccine for Streptococcus Equi

Also Published As

Publication number Publication date
AU2384600A (en) 2000-07-12
CA2353802A1 (fr) 2000-06-29
WO2000037648A1 (fr) 2000-06-29
EP1141311A1 (fr) 2001-10-10
JP2002533084A (ja) 2002-10-08
CA2353802C (fr) 2013-10-01

Similar Documents

Publication Publication Date Title
US7262024B2 (en) Streptococcus antigens
KR101078919B1 (ko) 신규한 스트렙토코커스 항원
JPH11514217A (ja) 結核の診断のための化合物および方法
KR19990022742A (ko) 스트렙토코커스 속 유래의 hsp70 계열의 쇼크 단백질
KR20010034518A (ko) 그룹 ｂ 스트렙토코커스 항원
US7160547B2 (en) Streptococcal streptolysin S vaccines
US7270827B2 (en) Multivalent streptococcal vaccine compositions and methods for use
JP2001500383A (ja) 結核診断用の化合物および方法
US20060039922A1 (en) Streptococcal heat shock proteins of the Hsp60 family
CA2353802C (fr) Nouvel antigene protecteur de streptococci du groupe a
US7063850B1 (en) Protective antigen of group A Streptococci
US20020086023A1 (en) Streptococcal streptolysin S vaccines
CA2331845A1 (fr) Composes et procedes servant a diagnostiquer et a traiter l'infection par ehrlichia
US20070122434A1 (en) Heat shock genes and proteins from Neisseria meningitidis, Candida glabrata and Aspergillus fumigatus
JPH09502604A (ja) Ｃａｍｐｙｌｏｂａｃｔｅｒｊｅｊｕｎｉ抗原、並びにそれらの製造及び利用
EP0871734B1 (fr) Fragments polypeptidiques capables de concurrencer l'antigene i/ii de streptococcus mutans
CA2265523A1 (fr) Acide nucleique et sequences d'acides amines relatifs a helicobacter pylori, et compositions de vaccins les contenant
AU764811B2 (en) A polypeptide comprising the amino acid of an n-terminal choline binding protein A truncate, vaccine derived therefrom and uses thereof
AU772898B2 (en) Streptococcal ABC transporter protein
US20040151737A1 (en) Streptococcal serum opacity factors and fibronectin-binding proteins and peptides thereof for the treatment and detection of streptococcal infection
EP1712629A2 (fr) Composés et procédés pour le diagnostic de la tuberculose
CA2470421A1 (fr) Utilisation de nouvelle proteine protease de surface cellulaire du groupe streptococcus (gbs), appelee cspa, comme vaccin destine a prevenir l'infection par le gbs.
CA2296869A1 (fr) Une lipoproteine a surface exposee de campylobacter jejuni participant a l'adhesion aux cellules hep-2
MXPA97009557A (en) Members of streptococal thermal shock proteins of the hs family
HK1099337A (en) Compounds and methods for diagnosis of tuberculosis

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)